Inhibrx Biosciences, Inc. Balance Sheet

Balance Sheet Dec2023 Dec2024
Assets
Assets 307.89M180.77M
Current Assets
Cash & Equivalents 277.92M152.60M
Receivables - Net 0.78M0.36M
Receivables - Other 0.61M0.04M
Receivables 1.39M0.40M
Prepaid Assets 16.66M7.38M
Current Assets 295.36M160.40M
Non-Current Assets
Property, Plant & Equipment (Net) 6.42M6.20M
Other Non-Current Assets 3.16M6.83M
Non-Current Assets 12.54M20.37M
Liabilities
Current Liabilities
Accounts Payables 10.95M9.24M
Payables 10.95M9.24M
Accumulated Expenses 43.30M29.89M
Current Leases 2.06M1.59M
Total Current Liabilities 56.31M40.73M
Non-Current Liabilities
Non-Current Debt 206.97M
Operating Leases 3.17M8.05M
Liabilities
Total Liabilities 264.39M47.18M
Shareholder's Equity
Total Debt 206.97M
Common Equity 43.50M133.58M
Shareholder's Equity 43.50M133.58M
Liabilities and Shareholders Equity 307.89M180.77M
Retained Earnings -613.73M-106.13M